Fig. 1From: Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy – a retrospective study including 32 patientsCumulative anthracycline dosage. Each patient is represented by a vertical bar. The patients are sorted by total cumulative dosage. In the light gray part, DRZ was coadministeredBack to article page